ABVC BioPharma Inc./$ABVC
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
- Ticker
- $ABVC
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- -
- Headquarters
- Fremont, United States
- Website
- www.abvcpharma.com
ABVC Metrics
BasicAdvanced
$27M
-
-$0.29
0.63
-
Price and volume
Market cap
$27M
Beta
0.63
52-week high
$3.06
52-week low
$0.71
Average daily volume
101K
Financial strength
Current ratio
0.072
Quick ratio
0.023
Long term debt to equity
0.115
Total debt to equity
0.235
Interest coverage (TTM)
-41.98%
Profitability
EBITDA (TTM)
-6.491
Effective tax rate (TTM)
-0.01%
Management effectiveness
Return on assets (TTM)
-22.85%
Return on equity (TTM)
-69.86%
Valuation
Price to book
2.58
Price to tangible book (TTM)
2.58
Price to free cash flow (TTM)
-9.621
Free cash flow yield (TTM)
-10.39%
Free cash flow per share (TTM)
-0.108
Growth
Earnings per share change (TTM)
-2.25%
3-year earnings per share growth (CAGR)
-57.80%
ABVC Financial Performance
Revenues and expenses
ABVC Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.